Esperion Therapeutics (NASDAQ:ESPR) Earns Buy Rating from Needham & Company LLC
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Related Keywords